Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. [electronic resource]
Producer: 20000214Description: 4097-104 p. digitalISSN:- 1078-0432
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- biosynthesis
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Glutathione S-Transferase pi
- Glutathione Transferase -- biosynthesis
- Head and Neck Neoplasms -- drug therapy
- Humans
- Isoenzymes -- biosynthesis
- Male
- Middle Aged
- Neoadjuvant Therapy
- Paclitaxel -- administration & dosage
- Retrospective Studies
- Thymidylate Synthase -- biosynthesis
- Treatment Outcome
- Tumor Suppressor Protein p53 -- biosynthesis
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.